Literature DB >> 1828189

Photosensitized release of von Willebrand factor from cultured human endothelial cells.

T H Foster1, M C Primavera, V J Marder, R Hilf, L A Sporn.   

Abstract

Cultured endothelial cells from the human umbilical vein were incubated with low concentrations (1 microgram/ml) of the photosensitizer Photofrin II. Following a sublethal light exposure, a light dose-dependent release of von Willebrand factor (vWf) into the culture medium was observed. Analysis of the multimeric composition of the released protein indicated that it originated from the intracellular pool of large vWf multimers stored in the Weibel-Palade bodies. This release was detected as early as 1 h postirradiation. Release was inhibited at low temperature and was dependent upon the presence of extracellular calcium. Photosensitization resulted in an influx of calcium whose time course paralleled vWf release from the cells. Since vWf mediates platelet adhesion to the vascular subendothelium, it is possible that its photochemically stimulated release in vivo could contribute to platelet thrombus formation observed in tissue following photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828189

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Prevention of late lumen loss after coronary angioplasty by photodynamic therapy: role of activated neutrophils.

Authors:  W Sluiter; W J de Vree; A Pietersma; J F Koster
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 2.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

3.  Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.

Authors:  J Gołab; G Wilczyński; R Zagozdzon; T Stokłosa; A Dabrowska; J Rybczyńska; M Wasik; E Machaj; T Ołda; K Kozar; R Kamiński; A Giermasz; A Czajka; W Lasek; W Feleszko; M Jakóbisiak
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

4.  BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells.

Authors:  J M Runnels; N Chen; B Ortel; D Kato; T Hasan
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

Review 5.  Design Principles of Hybrid Nanomaterials for Radiotherapy Enhanced by Photodynamic Therapy.

Authors:  Valeria Secchi; Angelo Monguzzi; Irene Villa
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

6.  Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster.

Authors:  M Leunig; A E Goetz; F Gamarra; G Zetterer; K Messmer; R K Jain
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

7.  Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.

Authors:  E Debefve; B Pegaz; H van den Bergh; G Wagnières; N Lange; J-P Ballini
Journal:  Angiogenesis       Date:  2008-03-07       Impact factor: 9.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.